NCT00062491 2020-03-12Study of Karenitecin (BNP1350) to Treat Malignant MelanomaBioNumerik Pharmaceuticals, Inc.Phase 2 Completed46 enrolled
NCT00358319 2013-11-25Phase I/II Trial of Valproic Acid and Karenitecin for MelanomaH. Lee Moffitt Cancer Center and Research InstitutePhase 1/2 Terminated42 enrolled